摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-[4-[4-(2-pyrimidinyl)piperazin-1-yl]butyl]-4,5-dihydro-2H-benzazepine-1,3-dione

中文名称
——
中文别名
——
英文名称
4-[4-[4-(2-pyrimidinyl)piperazin-1-yl]butyl]-4,5-dihydro-2H-benzazepine-1,3-dione
英文别名
2-(4-(4-(2-pyrimidinyl)piperazinyl)butyl)-1,3,4,5-tetrahydro-2-benzazepine-1,3-dione;2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-4,5-dihydro-2-benzazepine-1,3-dione
4-[4-[4-(2-pyrimidinyl)piperazin-1-yl]butyl]-4,5-dihydro-2H-benzazepine-1,3-dione化学式
CAS
——
化学式
C22H27N5O2
mdl
——
分子量
393.489
InChiKey
QQTOLSYAPVTAJC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    29
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    69.6
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    3-(2-羧基苯基)丙酸硫酸 、 sodium hydride 、 potassium carbonate氯化铵 、 sodium iodide 作用下, 以 1,4-二氧六环N,N-二甲基甲酰胺乙腈 为溶剂, 反应 504000.67h, 生成 4-[4-[4-(2-pyrimidinyl)piperazin-1-yl]butyl]-4,5-dihydro-2H-benzazepine-1,3-dione
    参考文献:
    名称:
    Synthesis, SAR studies, and evaluation of 1,4-benzoxazepine derivatives as selective 5-HT1A receptor agonists with neuroprotective effect: Discovery of Piclozotan
    摘要:
    A new series of 1,4-benzoxazepine derivatives was designed, synthesized, and evaluated for binding to 5-HT1A receptor and cerebral anti-ischemic effect. A lot of compounds exhibited nanomolar affinity for 5-HT1A receptor with good selectivity over both dopamine D, and alpha(1)-adrenergic receptors. Among these compounds, 3-chloro-4-[4-[4-(2-pyridinyl)-1,2,3,6-tetrahydropyridin-1-y]butyl]-1, 4-benzoxazepin-5(4H)-one (50: SUN N4057 (Piclozotan) as 2HCl salt) showed remarkable neuroprotective activity in a transient middle cerebral artery occlusion (t-MCAO) model. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2005.10.046
点击查看最新优质反应信息

文献信息

  • Fused 7-membered cyclic compound and antipsychotic preparation
    申请人:Suntory Limited
    公开号:US05312625A1
    公开(公告)日:1994-05-17
    A therapeutically effective antipsychotic preparation comprising a fused cyclic compound for the treatment of diseases involving the serotonergic pathway having the formula (I) or salts thereof: ##STR1## wherein both of A and B are carbonyl groups, or one represents a methylene group and the other a carbonyl group, Z represents a sulfur atom, or a nitrogen atom which may be substituted, or a methylene group, R represents an aromatic or heterocylcic group, which may be substituted, X represents a hydrogen atom, a halogen atom, a C.sub.1 -C.sub.5 lower alkyl group, a C.sub.1 -C.sub.5 lower alkoxy group, a C.sub.7 -C.sub.9 arylalkoxy group, a C.sub.1 -C.sub.5 lower acyloxy group, a C.sub.7 -C.sub.10 arylcarbonyloxy group, a hydroxy group, a nitro group or an ester group, and n is an integer of 2 to 10.
    一种治疗涉及血清素通路疾病的疗效良好的抗精神病制剂,包括具有公式(I)或其盐的融合环化合物: ##STR1## 其中A和B均为羰基基团,或者一个表示亚甲基基团,另一个表示羰基基团,Z表示硫原子,或者可被取代的氮原子或亚甲基基团,R表示芳香或杂环基团,可被取代,X表示氢原子、卤原子、C.sub.1-C.sub.5低碳基、C.sub.1-C.sub.5低烷氧基、C.sub.7-C.sub.9芳基烷氧基、C.sub.1-C.sub.5低酰氧基、C.sub.7-C.sub.10芳基羰基氧基、羟基、硝基或酯基,n为2至10的整数。
  • Fused 7-membered cyclic compound and antipsychotic preparation containing the same
    申请人:SUNTORY LIMITED
    公开号:EP0444924B1
    公开(公告)日:1996-01-03
  • US5312625A
    申请人:——
    公开号:US5312625A
    公开(公告)日:1994-05-17
  • Synthesis, SAR studies, and evaluation of 1,4-benzoxazepine derivatives as selective 5-HT1A receptor agonists with neuroprotective effect: Discovery of Piclozotan
    作者:Katsuhide Kamei、Noriko Maeda、Kayoko Nomura、Makoto Shibata、Ryoko Katsuragi-Ogino、Makoto Koyama、Mika Nakajima、Teruyoshi Inoue、Tomochika Ohno、Toshio Tatsuoka
    DOI:10.1016/j.bmc.2005.10.046
    日期:2006.3
    A new series of 1,4-benzoxazepine derivatives was designed, synthesized, and evaluated for binding to 5-HT1A receptor and cerebral anti-ischemic effect. A lot of compounds exhibited nanomolar affinity for 5-HT1A receptor with good selectivity over both dopamine D, and alpha(1)-adrenergic receptors. Among these compounds, 3-chloro-4-[4-[4-(2-pyridinyl)-1,2,3,6-tetrahydropyridin-1-y]butyl]-1, 4-benzoxazepin-5(4H)-one (50: SUN N4057 (Piclozotan) as 2HCl salt) showed remarkable neuroprotective activity in a transient middle cerebral artery occlusion (t-MCAO) model. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多